Tekla Healthcare Investors Stock Performance
| HQH Stock | USD 17.95 0.05 0.28% |
Tekla Healthcare has a performance score of 7 on a scale of 0 to 100. The entity has a beta of 0.48, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tekla Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tekla Healthcare is expected to be smaller as well. Tekla Healthcare Inv right now has a risk of 1.03%. Please validate Tekla Healthcare total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Tekla Healthcare will be following its existing price patterns.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Tekla Healthcare Investors are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Tekla Healthcare is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 0.28 | Five Day Return 0.11 | Year To Date Return 10.6 | Ten Year Return (47.39) | All Time Return 84.1 |
Forward Dividend Yield 0.127 | Payout Ratio | Forward Dividend Rate 2.28 | Dividend Date 2018-12-31 | Ex Dividend Date 2025-02-21 |
| Tekla Healthcare dividend paid on 21st of November 2024 | 11/21/2024 |
1 | Acquisition by Dimartino Rose of 1000 shares of Tekla Healthcare at 18.88 subject to Rule 16b-3 | 11/22/2024 |
2 | Insider Trading | 12/10/2024 |
| Tekla Healthcare dividend paid on 10th of January 2025 | 01/10/2025 |
3 | abrdn Healthcare Investors declares 0.57 dividend | 02/11/2025 |
| Begin Period Cash Flow | 214.00 |
Tekla |
Tekla Healthcare Relative Risk vs. Return Landscape
If you would invest 1,698 in Tekla Healthcare Investors on November 18, 2024 and sell it today you would earn a total of 97.00 from holding Tekla Healthcare Investors or generate 5.71% return on investment over 90 days. Tekla Healthcare Investors is generating 0.0963% of daily returns assuming volatility of 1.0288% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than Tekla, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Tekla Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tekla Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tekla Healthcare Investors, and traders can use it to determine the average amount a Tekla Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0936
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | HQH | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.03 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Tekla Healthcare is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tekla Healthcare by adding it to a well-diversified portfolio.
Tekla Healthcare Fundamentals Growth
Tekla Stock prices reflect investors' perceptions of the future prospects and financial health of Tekla Healthcare, and Tekla Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tekla Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | -1.0E-4 | ||||
| Profit Margin | 17.17 % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 935.73 M | ||||
| Shares Outstanding | 52.13 M | ||||
| Price To Earning | 3.38 X | ||||
| Price To Book | 0.88 X | ||||
| Price To Sales | 86.89 X | ||||
| Revenue | 10.77 M | ||||
| Gross Profit | 10.77 M | ||||
| EBITDA | 56.33 M | ||||
| Net Income | 184.95 M | ||||
| Cash And Equivalents | 62 | ||||
| Total Debt | 1.4 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 20.33 X | ||||
| Cash Flow From Operations | (65.41 M) | ||||
| Earnings Per Share | 3.53 X | ||||
| Market Capitalization | 935.73 M | ||||
| Total Asset | 1.06 B | ||||
| Retained Earnings | 117.95 M | ||||
About Tekla Healthcare Performance
By evaluating Tekla Healthcare's fundamental ratios, stakeholders can gain valuable insights into Tekla Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tekla Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tekla Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.17 | 0.18 | |
| Return On Assets | 0.17 | 0.18 | |
| Return On Equity | 0.17 | 0.18 |
Things to note about Tekla Healthcare Inv performance evaluation
Checking the ongoing alerts about Tekla Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tekla Healthcare Inv help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tekla Healthcare Inv has high likelihood to experience some financial distress in the next 2 years | |
| Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations. | |
| Tekla Healthcare Inv has a poor financial position based on the latest SEC disclosures | |
| On 10th of January 2025 Tekla Healthcare paid $ 0.62 per share dividend to its current shareholders | |
| Latest headline from seekingalpha.com: abrdn Healthcare Investors declares 0.57 dividend |
- Analyzing Tekla Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tekla Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Tekla Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tekla Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tekla Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tekla Healthcare's stock. These opinions can provide insight into Tekla Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |